The role of IL-29 in immunity and cancer-Reference-Cited by-同舟云学术

The role of IL-29 in immunity and cancer

Published:2016-10 Issue: Volume:106 Page:91-98
ISSN:1040-8428
Container-title:Critical Reviews in Oncology/Hematology
language:en
Short-container-title:Critical Reviews in Oncology/Hematology

Author:

Kelm Noah E.,Zhu Ziwen,Ding Vivi A.,Xiao Huaping,Wakefield Mark R.,Bai Qian,Fang Yujiang

Funder

Des Moines University for Yujiang Fang

IOER

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference103 articles.

1. p21 in cancer: intricate networks and multiple activities;Abbas;Nat. Rev. Cancer,2009

2. Insights into the role of HCV plus-/minus strand RNA, IFN-γ and IL-29 in relapse outcome in patients infected by HCV;Alborzi;Asian Pac. J. Allergy Immunol.,2015

3. Interleukin-10 induces both plasma cell proliferation and angiogenesis in multiple myeloma;Alexandrakis;Pathol. Oncol. Res.,2015

4. Lambda interferon (IFN-λ), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo;Ank;J. Virol.,2006

5. Molecular, cellular and physiological characterization of the cancer cachexia-inducing C26 colon carcinoma in mouse;Aulino;BMC Cancer,2010

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular characteristics of rhesus macaque interferon-lambda receptor 1 (mmuIFNLR1): Sequence identity, distribution and alteration after simian-human immunodeficiency virus infection in the skin and buccal mucosa;Developmental & Comparative Immunology;2024-11

2. Exosomes-based immunotherapy for cancer: Effective components in the naïve and engineered forms;International Immunopharmacology;2024-09

3. Effect of sitagliptin therapy on IL-29 and its associated signaling molecules in patients with type 2 diabetes mellitus;Human Immunology;2024-07

4. Evaluation of the serum levels of CCL2, CCL3, and IL-29 after first and second administrations of the COVID-19 vaccine (Oxford–AstraZeneca);Immunobiology;2024-03

5. Up and away with cervical cancer: IL-29 is a promising cytokine for immunotherapy of cervical cancer due to its powerful upregulation of p18, p27, and TRAILR1;Medical Oncology;2024-01-28